World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
16798
World Ranking
2827
National Ranking
1339

Arthur Y. Kim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arthur Y. Kim sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 255 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arthur Y. Kim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arthur Y. Kim sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arthur Y. Kim is affiliated with Harvard University in the United States and has contributed extensively to the field of medicine, particularly focusing on infectious diseases, epidemiology, and hepatology. Their scholarly work includes 174 publications within medicine, with 51 specifically related to infectious diseases, 48 in epidemiology, and 43 in hepatology. Additional subfields of study include immunology and neurology.

The scientist's research topics cover a broad range of subjects related to viral infections and liver diseases. Key topics include Hepatitis C virus research, COVID-19 clinical research studies, Hepatitis B virus studies, HIV, drug use, and sexual risk, SARS-CoV-2 and COVID-19 research, liver disease diagnosis and treatment, and HIV/AIDS research and interventions.

Arthur Y. Kim has authored several notable papers. Among the recent publications are:

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 (2020), published in New England Journal of Medicine
  • Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection (2020), published in Nature Communications
  • Liver Biochemistries in Hospitalized Patients With COVID-19 (2020), published in Hepatology
  • Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans (2021), published in Nature Immunology
  • Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19 (2020), published in Journal of the American Society of Nephrology

Collaborations with other researchers have been frequent, with a number of co-authors contributing to their research output. Frequent co-authors include Moonseong Heo, Shruti H. Mehta, Lynn E. Taylor, Alain H. Litwin, and Judith I. Tsui, with collaboration counts ranging from 19 to 22 publications each.

The scientist's work is also published in a variety of prominent venues. Among the most frequent publication channels are bioRxiv (Cold Spring Harbor Laboratory), Drug and Alcohol Dependence, Journal of Hepatology, Open Forum Infectious Diseases, and Clinical Infectious Diseases.

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.

    John H. Stone;Matthew J. Frigault;Naomi J. Serling-Boyd;Ana D. Fernandes

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

    Georg M. Lauer;Eleanor Barnes;Eleanor Barnes;Michaela Lucas;Joerg Timm

  • CD8 Epitope Escape and Reversion in Acute HCV Infection

    Joerg Timm;Georg M. Lauer;Daniel G. Kavanagh;Isabelle Sheridan

  • Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

    Meghan E. Sise;Allyson K. Bloom;Jessica Wisocky;Ming V. Lin

  • Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

    Ting Yi Chen;Eric L. Ding;George R. Seage;Arthur Y. Kim

  • Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence

    Julian Schulze zur Wiesch;Julian Schulze zur Wiesch;Donatella Ciuffreda;Lia Lewis-Ximenez;Victoria Olivia Kasprowicz

  • Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection.

    Niyati Desai;Azfar Neyaz;Annamaria Szabolcs;Angela R. Shih

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.

    Georg M. Lauer;Kei Ouchi;Raymond T. Chung;Tam N. Nguyen

  • High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome

    Victoria Kasprowicz;Julian Schulze zur Wiesch;Julian Schulze zur Wiesch;Julian Schulze zur Wiesch;Thomas Kuntzen;Brian E. Nolan

  • Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes

    Julian Schulze zur Wiesch;Georg M. Lauer;Cheryl L. Day;Arthur Y. Kim

  • Coinfection With HIV-1 and HCV—A One-Two Punch

    Arthur Y. Kim;Raymond T. Chung

  • Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

    Kathleen B. Yates;Kathleen B. Yates;Pierre Tonnerre;Pierre Tonnerre;Genevieve E. Martin;Genevieve E. Martin;Ulrike Gerdemann

  • Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection

    R. Draenert;C. L. Verrill;Y. Tang;T. M. Allen

  • Liver Biochemistries in Hospitalized Patients With COVID-19.

    Patricia P. Bloom;Eric A. Meyerowitz;Zoe Reinus;Michael Daidone

  • Fc Glycan-Mediated Regulation of Placental Antibody Transfer

    Madeleine F Jennewein;Ilona Goldfarb;Sepideh Dolatshahi;Sepideh Dolatshahi;Cormac Cosgrove

  • Hepatitis C Virus.

    Arthur Kim

  • CTL epitope escape and reversion in acute HCV infection.

    J Timm;G Lauer;D Kavanagh;A Kim

Frequent Co-Authors

Georg M. Lauer
Georg M. Lauer Harvard University
Raymond T. Chung
Raymond T. Chung Harvard University
Todd M. Allen
Todd M. Allen Harvard University
Bruce D. Walker
Bruce D. Walker Harvard University
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine
Margaret Hellard
Margaret Hellard Burnet Institute
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
Lisa Maher
Lisa Maher University of New South Wales
Gregory J. Dore
Gregory J. Dore University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse pathways in healthcare and research. Many students interested in clinical applications explore roles such as nurse practitioners, a field that blends patient care with scientific understanding.

For those pursuing advanced nursing roles, obtaining an acute care nurse practitioner certification is a key step. This specialization focuses on critical and complex patient care, complementing immunology knowledge when treating immune-related conditions.

Accelerated pathways like a nurse practitioner accelerated program offer a fast-tracked option for professionals seeking quicker entry into these roles. These programs often build on foundational science backgrounds, including immunology.

For those beginning their journey, online BSN programs for non nurses provide accessible routes into nursing without prior healthcare experience. Combined with an interest in immunology, these programs allow students to bridge theory and patient care effectively.

Finding programs with high acceptance rates can be crucial, and ABSN programs with high acceptance rates make it easier for motivated students to start their nursing careers and apply immunological expertise in clinical settings.

Best Scientists Citing Arthur Y. Kim

Trending Scientists

Recently Published Articles